Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.
Metrics to compare | AMIX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAMIXPeersSector | |
---|---|---|---|---|
P/E Ratio | −0.2x | −7.2x | −0.6x | |
PEG Ratio | 0.01 | 0.16 | 0.00 | |
Price / Book | 1.0x | 4.0x | 2.6x | |
Price / LTM Sales | - | 4.4x | 3.1x | |
Upside (Analyst Target) | - | 48.5% | 55.2% | |
Fair Value Upside | Unlock | −0.4% | 9.8% | Unlock |